Form D · Venture Capital Fund
NSV2 Feanix Bio SPV1 LP
Fort Lauderdale, FL · CIK 0002154441
Offering snapshot reported Sep 15, 2026 · SEC filing
- Reported sold
- $1.19M Indefinite offering
- Investors reported
- 42 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 13, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 15, 2026 | Initial | $1,193,250 | No comparison | 42 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-597547
Source: Form D, filed Sep 15, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nsv2 Gp Llc | Promoter |
| Nsvm Llc | Promoter |
| Alan Rutledge | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
1323 Se 17 Th St. #91308
Fort Lauderdale, FL, 33316
Fort Lauderdale, FL, 33316